Ketamine blocks the NMDA glutamate receptor, not 5-HT2A: and relief can come within hours. In rats it triggers new synapses in the frontal cortex; in people the mechanism is still debated. A nasal form is US-approved, given in a clinic; it fades in days, and the risks are real.
Loading brain…